• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 55Adverse events assessed systematically of rTMS versus sham: Tier 1, MDD

Author, Year
Design
Outcome scale
Quality
Intervention and Sample Size
Study Details
Adverse Events (Pain, Concentration, Sleep)
Avery et al., 200677,99
RCT
SAFTEE Scores
Good
rTMS (n = 35)
High frequency, 15 sessions over 4 weeks
Sham (n = 33)
SAFTEE Scores
Scalp pain at the stimulation site,%
Session 1:
rTMS: 41 vs. sham: 0, P < 0.05
Session 15:
rTMS: 33 vs. sham: 3, P < 0.05
Seizures, n:
rTMS: 0 vs. sham: 0
Changes in SAFTEE (from baseline in 128 individual scores for any emerging symptoms that suggest adverse effects):
rTMS vs. sham P = NS (Data = NR)

N = number; NS = not significant; RCT = randomized controlled trial; rTMS = repetitive transcranial magnetic stimulation; SAFTEE = Systematic Assessment for Treatment Emergent Effects

From: Results

Cover of Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults
Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults [Internet].
Comparative Effectiveness Reviews, No. 33.
Gaynes BN, Lux LJ, Lloyd SW, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.